• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Business Directory
    • Buyers | Licensees
    • Sellers | Ancillary Businesses
    • Submit Product & Service Press Release
  • CBE Exchange
  • CBE Jobs Exchange
  • Events
  • Featured Videos
  • Product & Service Press Releases
  • Sponsored Polls
  • Webinars
    • Upcoming Webinars
    • Archived Webinars
  • Whitepapers

Cannabis Business Executive - Cannabis and Marijuana industry news

Recreational, Medical, Marijuana, Cannabis, And Hemp News for Cannabis Businesses

  • Follow on Facebook
  • Follow on Twitter
  • Follow on Google+
  • Follow on LinkedIn
  • Subscribe to our RSS feed
Newsletter 2
  • Home
  • Policy & Legal
    • Hemp Business Executive
    • International
      • Canada
      • Mexico
      • Israel
    • US A to F
      • Alabama
      • Alaska
      • Arizona
      • Arkansas
      • California
      • Colorado
      • Connecticut
      • Delaware
      • District of Columbia
      • Florida
    • US G to M
      • Georgia
      • Hawaii
      • Illinois
      • Indiana
      • Idaho
      • Iowa
      • Kansas
      • Kentucky
      • Louisiana
      • Maine
      • Maryland
      • Massachusetts
    • US M to N
      • Michigan
      • Minnesota
      • Mississippi
      • Missouri
      • Montana
      • Nebraska
      • Nevada
      • New Hampshire
      • New Jersey
      • New Mexico
      • New York
      • North Carolina
      • North Dakota
    • US O to V
      • Ohio
      • Oklahoma
      • Oregon
      • Pennsylvania
      • Rhode Island
      • South Carolina
      • South Dakota
      • Tennessee
      • Texas
      • Utah
      • Vermont
    • US V to W
      • Virginia
      • Washington
      • Wisconsin
      • Wyoming
      • Guam
      • Puerto Rico
  • News & Insights
    • Advertising, Marketing, PR & Research
    • Banking, Finance & Real Estate
    • Compliance and Regulations
    • Corporate Social Responsibility
    • Retailers
    • Hemp Business Executive
    • HR and Staffing
    • North Of The Border
    • Industry People/On the Move
    • Packaging and Supplies
    • Press Releases
    • Processors
    • Producers
    • Security Solutions
    • Science and Technology
    • South Of The Border
  • CBE Lists
    • Ancillary Businesses
      • 2019 CBE Ancillary Business Survey CLICK HERE
      • 2018 CBE 155 A/B
      • 2017 CBE 150 A/B
      • 2016 CBE 100 A/B
    • Producers, Processors, Retailers
      • 2017 CBE 200 PPRs
      • 2015 CBE 100 PPRs
    • Industry Women
      • Glass Ceiling Wreckers: 2019 CBE Power Women of Cannabis
      • 2017 CBE 75 Most Important Women
      • 2016 CBE Top 50 Women
      • 2014 CBE Most Influential Women
    • Most Important Companies
      • 2016 CBE 10 Most Important Companies
      • 2014 CBE 10 Most Important Companies
    • Political 100
      • 2017 CBE Political 100
      • 2016 CBE 100 Political
      • 2014 CBE Political 50
    • 2014 CBE 100 Most Important People
    • CBE RFP Hotlists
      • 2014 CBE Lab Testing Services HotList
      • 2016 BHO Extraction Equipment
      • 2016 CBE Supercritical CO2 Extraction Equipment
      • 2016 CBE Security Solutions
      • 2016 Edibles & Infused Products
  • Company Stories
    • Up and Comers
  • Hemp Business Executive
    • Hemp Policy & Legal
    • Hemp Industry News
    • Hemp State Regulatory Agencies
  • Newsletters
    • CBE News & Insights (Formerly CBE Week)
    • CBE Human Capital Management
    • CBE Technology & Solutions
    • CBE Policy and Legal
    • CBE Product and Service Announcements
  • Op-Ed
    • Cartoons
    • The Buck Stops Here
    • Opinions
    • Comments
  • Associations
  • State Regulatory Agencies
    • Marijuana
    • Hemp
  • Contact
  • AB Survey
  • About Us
  • Account
  • Accounting Services
  • Advertise
  • Advertising, PR & Marketing
  • All Cannabis News
  • Ancillary Business Survey 2018
  • Ancillary Business Survey 2019
  • Archived Webinars
  • Associations & Organizations
  • Banking & Payment Processing
  • Better Start for the Glass Ceiling in this Industry, CBE’s Most Influential Women
  • Book Reviews
  • Business Directory
  • Business Directory Introduction
  • Business Directory Listing
  • Business Directory Manage
  • Business Directory Registration Info
  • Business Directory Welcome
  • Call for speakers
  • Cannabis Investments
  • Cart
  • CBE Exchange
  • CBE HotLists
    • CBE Lab Testing Services HotList 2014
  • CBE Lists
  • CBE Political 50
  • CBE Press LLC Privacy Statement
  • CBE Press News
  • Checkout
  • Consulting Services
  • Consumption Gear
  • Contact
  • Contribute
  • Contributors
  • Create Your Product & Service Press Release
  • Creative Submission
  • Cultivation Products & Services
  • Current Poll
  • Edible & Infused Products
  • Editor’s Page
  • Email Whitelisting Instructions
  • Event Listing Questionaire
  • Featured Videos
  • Funding Options
  • Hemp State Regulatory List
  • Home
  • Human Capital Management Newsletters
  • Industry Jobs
  • Join the CBE Business Directory
  • Join the Directory
  • Lab Testing Regulations
  • Lab Testing Services
  • Login
  • Logout
  • Marijuana State Regulatory Contacts
  • Marijuana Tax Facts
  • Media Kit
  • Media Kit
  • Medical Marijuana Qualifying Conditions
  • Members
  • MJ Media Kit
  • Most Popular Stories
  • Most Read Stories
  • New Product & Service Listings Welcome
  • Newsletters
    • Ask CBE
    • CBE Human Capital Management
    • CBE News & Insights (Formerly CBE Week)
    • CBE Policy and Legal
    • CBE Product and Service Announcements
    • CBE Technology & Solutions
  • On the Move
  • Organizations & Associations
  • Packaging & Supplies
  • Password Reset
  • Policy & Legal
  • PPR Survey
  • PR Newswire
  • Product Releases
  • Profile Update
  • Register
  • Security Solutions
  • Software & Technology
  • Sponsored Polls
  • State Cannabis Product Packaging Requirements
  • Terms of Service
  • Thank You
  • The Most Influential People in the Cannabis Industry, The Cannabis Business Executive 100
  • Training & Educational Services
  • Upcoming Webinars
  • User
  • Whitepapers
  • WV Senate passes medical marijuana bill to House
  • Categories
  • Locations
  • My Bookings
You are here: Home / Hemp Business Executive / Hemp Policy & Legal / Hemp-Derived THC Products: Legal or Loophole?

Hemp-Derived THC Products: Legal or Loophole?

May 26, 2020 by Ian Stewart Leave a Comment

By Ian A. Stewart, Devon Mills and Neil Willner

Hemp-derived CBD products have exploded onto the market since Congress removed hemp from the Controlled Substances Act (CSA) in the 2018 Farm Bill. Now, new hemp-derived products are emerging that contain amounts of THC comparable to state-regulated marijuana consumer products, which are still illegal under federal law and highly regulated by states with adult-use and medical cannabis programs. These new “hemp-derived THC” products present a novel question: Do they impermissibly exploit a legal loophole or are they the first THC products that legitimately fall outside the CSA? Answering this question requires an understanding of the legalization of hemp-derived consumer products.

Hemp-Derived THC and the CSA

Congress legalized hemp in the 2018 Farm Bill by amending the CSA in two ways. First, Congress removed hemp from the CSA’s definition of marijuana by excluding any part of the marijuana plant with less than 0.3% THC by dry weight concentration. Second, hemp derivatives with less than 0.3% THC concentration also were removed from the CSA. Any THC that is derived from compliant hemp could therefore – in theory – legally cross state lines and be sold without fear of prosecution under the CSA. Indeed, a perhaps unintended consequence of the Farm Bill in this context is its strict prohibition on state interference with the interstate transportation or shipment of hemp or hemp products that are produced under an approved state plan.

Hemp-Derived THC and the FDA

The 2018 Farm Bill also explicitly preserved the authority of the Food and Drug Administration (FDA) to regulate products containing cannabis or cannabis-derived compounds under the Federal Food, Drug and Cosmetic Act. The FDA currently prohibits THC or CBD products from being sold as dietary supplements or as food additives, though the agency is actively investigating whether a pathway should exist for certain CBD ingestible products through the agency’s rulemaking process.

Hemp-Derived THC and State Law

At the state level, the 2018 Farm Bill permits states to implement their own regulatory scheme for the production of hemp so long as the plan is approved by the U.S. Department of Agriculture (USDA). States that wish to maintain primary regulatory authority over the production of hemp within their borders must submit a plan to the USDA that includes, among other things, “a procedure for testing, using post-decarboxylation or other similarly reliable methods, delta-9 tetrahydrocannabinol (THC) concentration levels of hemp produced in the State.” The Farm Bill is silent, however, on states’ ability to regulate hemp-derived products. Several states have nevertheless adopted stringent labeling, packaging and testing rules for hemp-derived products.

Colorado, for example, has specific labeling requirements such as clearly identifying hemp as an ingredient, identifying CBD in the product, including the statement “FDA has not evaluated this product for safety or efficacy,” and ensuring the label does not contain any health or benefit claims. Colorado also requires all finished hemp-derived products to have a concentration of 0.3% THC or below to enter the consumer market.

Several other states, such as Oregon, Texas and Ohio have similar requirements. Many states remain silent on hemp-derived consumer product requirements under state law. Other states expressly prohibit hemp-derived CBD products regardless of the relative concentrations of CBD or THC in the product. Any company that wishes to sell hemp-derived consumer products must therefore adopt a state-by-state risk management approach.

Example of a Hemp-Derived THC Product

Cannabinoid-infused products come in many forms. If a company wanted to produce a product with a meaningful concentration of hemp-derived THC comparable to traditional marijuana products, it must at a minimum ensure that the product contains less than 0.3% concentration of THC. So, for example, if a product serving contains 10mg of THC, which is comparable to a traditional regulated marijuana product, the product would need to weigh 3.33 grams to fall below the 0.3% THC requirement. The weight of an average gummy gelatin product is 2.6 grams.

Discussion

So where do hemp-derived THC products fall within this complicated legal landscape? The short and admittedly simplistic answer is that these products in ingestible form (1) are prohibited under current FDA guidelines, (2) may or may not be legal under state law depending on the state, and (3) appear to comply with a strict reading of what is legal under the 2018 Farm Bill. In short, they appear to fall outside the CSA.

It is important to keep in mind that the Farm Bill and related state hemp plans only regulate the cultivation of hemp, not the use of hemp in consumer products. If a manufacturer is able to ensure the hemp used to produce its product is compliant with less than 0.3% THC on a dry weight basis, the USDA should not intervene. The FDA’s restrictive position on THC in any ingestible form is clear, though the agency has traditionally deferred enforcement of THC-related issues to the Department of Justice and state law enforcement. That may change if hemp-derived THC products proliferate.

Again, state law requires a state-by-state analysis to determine whether a product is legal. There is no “one size fits all” solution and, depending on where a product is sold, there may be labeling, testing and other restrictions to satisfy before a hemp-derived product may be sold legally. To date, states that have enacted state regulations have focused on hemp-derived CBD – not THC or the so-called “novel” cannabinoids such as CBG, CBN and THCA.

Another important question is whether these products are misleading and subject to false advertising or deceptive consumer practices lawsuits. General public confusion regarding marijuana, hemp, CBD and THC is well documented. Intoxicating products that are marketed as federally legal could give rise to substantial civil liability under consumer protection statutes.

Hemp-derived THC products technically may not violate federal criminal law because they fall within an unintended legal loophole, but they certainly violate the spirit of federal law and should be handled with extreme caution until THC is formally removed from the CSA. After all, federal authorities have taken a hands-off approach to THC products only within the context of well-regulated state systems. Lingering uncertainty as to the legal status of these products will need to be addressed through legislation or by the courts. In the meantime, caution is warranted.

 

 

Contextual Links

Filed Under: Hemp Policy & Legal Tagged With: 2018 Farm Bill, Controlled Substance Act (CSA), Food and Drug Administration (FDA), FoodDrug and Cosmetic Act (FDCA), Hemp Derived CBD, U.S. Department of Agriculture (USDA)

About Ian Stewart

Ian is a partner in the Los Angeles office of Wilson Elser. He is co-founder and chair of the Wilson Elser Cannabis Law practice and uses his 20 years of legal experience to help clients navigate the legalities around cannabis and hemp. Ian works with licensed cannabis operators to comply with their obligations under the law and to develop risk management best practices. He also regularly consults with insurance companies to assist with cannabis-related underwriting practices and the development of new policy forms.

He is currently Chair of the National Cannabis Industry Association’s Finance and Insurance Committee, as well as Vice-Chair of the California Cannabis Industry Association’s Insurance Committee. Ian received his B.A. from Washington University in St. Louis, and his JD from St. Louis University. He has been with Wilson Elser for the past 18 years.

Primary Sidebar

Ad: Sidebar 1

Featured Video

Associations & Organizations

clearing div

Ad: Sidebar 2

Business Directory

Ad: Skyscraper 1

CBE Jobs Exchange


Featured Jobs
Go
Post a Job
More jobs
Powered by CBEJobsExchange.com

RSS Recent Jobs

  • Senior Account Executive (Marketing & PR) - Acceleration Community of Companies - Los Angeles, CA
  • Administrative Law Judge - Temporary Appointment - WA State: Office of Administrative Hearings - Multiple Locations Statewide, WA
  • Senior Research Biostatistician - TSET Health Promotion Research Center at Stephenson Cancer Center/OUHSC - Oklahoma City, OK

Product & Service Press Releases

Ad: Sidebar 3

CBE Events

Ad: Sidebar 4

State Regulatory Agencies

Ad: Skyscraper 2

Webinars

Ad: Sidebar 5

Associations & Organizations

Ad: Sidebar 6

Featured Video

Ad: Skyscraper 3

Business Directory

Ad: Sidebar 7

CBE Jobs Exchange

Ad: Sidebar 8

CBE Events

Ad: Skyscraper 4

Footer

  • Home
  • About Us
  • Advertise
  • Contact
  • CBE Press LLC Privacy Statement
  • Contribute
  • Contributors
  • Newsletters
  • Terms of Service
  • Contributor Login
  • Follow on Facebook
  • Follow on Twitter
  • Follow on Google+
  • Follow on LinkedIn
  • Subscribe to our RSS feed
Newsletter 2

© Copyright 2020 CBE PRESS LLC. - All Rights Reserved. Cannabis Business Executive Is A Trademark Of CBE PRESS LLC. · All Rights Reserved · And Our Sitemap · All Logos & Trademarks Belong To Their Respective Owners·